Cargando…

Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis

BACKGROUND: Recent studies have shown that radiation-induced pelvic toxicity often requires urological consultation. However, the 10-year incidence of genitourinary toxicity following intensity-modulated radiotherapy (IMRT) amongst patients with localised prostate cancer remains unclear. Hence, we c...

Descripción completa

Detalles Bibliográficos
Autores principales:	David, Rowan, Buckby, Alex, Kahokehr, Arman A., Lee, Jason, Watson, David I., Leung, John, O’Callaghan, Michael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023565/ https://www.ncbi.nlm.nih.gov/pubmed/35260794 http://dx.doi.org/10.1038/s41391-022-00520-x

Ejemplares similares

Incidence of genitourinary complications following radiation therapy for localised prostate cancer
por: David, Rowan V., et al.
Publicado: (2022)

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer
por: David, Rowan, et al.
Publicado: (2022)

Risk of secondary malignancy following radiation therapy for prostate cancer
por: Tiruye, Tenaw, et al.
Publicado: (2023)

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
por: Fornacon-Wood, Isabella, et al.
Publicado: (2022)

Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose
por: Li Kuan Ong, Ashley, et al.
Publicado: (2023)

Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
por: Hunter, Grant K., et al.
Publicado: (2012)

Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy
por: Valle, Luca F., et al.
Publicado: (2020)

Intraperitoneal local anesthetic for postoperative pain
por: Kahokehr, Arman
Publicado: (2013)

Posterior urethral stenosis after prostate cancer treatment: contemporary options for definitive management
por: Kahokehr, Arman A., et al.
Publicado: (2018)

Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC
por: MacManus, Michael, et al.
Publicado: (2023)

Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis
por: Li, Xuanzhe, et al.
Publicado: (2023)

Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
por: Kamran, Sophia C., et al.
Publicado: (2021)

Renocolic fistula secondary to curative intent extended field radiotherapy for cervical cancer
por: Thiyagarajan, Dhanalakshmi, et al.
Publicado: (2018)

Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients
por: Miszczyk, Marcin, et al.
Publicado: (2018)

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial
por: Kim, Julian O., et al.
Publicado: (2021)

Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy
por: Olsson, C E, et al.
Publicado: (2013)

Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon
por: Deville, Curtiland, et al.
Publicado: (2012)

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
por: Tanaka, Nobumichi, et al.
Publicado: (2013)

Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients
por: Liao, D., et al.
Publicado: (2021)

Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice
por: Inokuchi, Haruo, et al.
Publicado: (2017)

The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent
por: Rajasooriyar, Chrishanthi, et al.
Publicado: (2014)

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers
por: Li, Haoran, et al.
Publicado: (2022)

Genitourinary
por: Santh Kumar, B
Publicado: (2008)

Genitourinary
por: Santh Kumar, B
Publicado: (2008)

Genitourinary
Publicado: (2006)

Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study
por: Delgadillo, Rodrigo, et al.
Publicado: (2022)

Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis
por: Jani, Ashesh B, et al.
Publicado: (2003)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Recent advances in the understanding of male lower urinary tract symptoms (LUTS)
por: Kahokehr, Arman A., et al.
Publicado: (2016)

Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study
por: He, Xiaofeng, et al.
Publicado: (2018)

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic
por: Faivre-Finn, C., et al.
Publicado: (2020)

87: Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients
por: Liao, Donna, et al.
Publicado: (2021)

Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
por: Reverberi, C., et al.
Publicado: (2020)

Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity
por: Rudat, Volker, et al.
Publicado: (2015)

Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study
por: Li, Youquan, et al.
Publicado: (2022)

Intensity-modulated radiotherapy for prostate cancer
por: Fischer-Valuck, Ben W., et al.
Publicado: (2018)

GENITOURINARY CANCER
Publicado: (1979)

Genitourinary tuberculosis
por: Gupta, Narmada P.
Publicado: (2008)

Genitourinary rhinosporidiosis
por: Pal, Dilip Kumar, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_b9l6sgsc9p2eqcl5u9k57s0k94